NO964451L - Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer - Google Patents

Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer

Info

Publication number
NO964451L
NO964451L NO964451A NO964451A NO964451L NO 964451 L NO964451 L NO 964451L NO 964451 A NO964451 A NO 964451A NO 964451 A NO964451 A NO 964451A NO 964451 L NO964451 L NO 964451L
Authority
NO
Norway
Prior art keywords
pharmaceutically acceptable
ray contrast
compositions containing
containing pharmaceutically
contrast compositions
Prior art date
Application number
NO964451A
Other languages
English (en)
Norwegian (no)
Other versions
NO964451D0 (no
Inventor
Stephen B Ruddy
Gregory L Mcintire
Mary E Roberts
John L Toner
Edward R Bacon
Tom Caufield
Eugene R Cooper
Brent D Douty
Carl R Illig
Kimberly Estep
Original Assignee
Nycomed Imaging As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/230,580 external-priority patent/US5476646A/en
Priority claimed from US08/236,287 external-priority patent/US5424056A/en
Priority claimed from US08/237,502 external-priority patent/US5492687A/en
Priority claimed from US08/239,090 external-priority patent/US5484585A/en
Priority claimed from US08/247,424 external-priority patent/US5360604A/en
Priority claimed from US08/247,438 external-priority patent/US5531979A/en
Priority claimed from US08/249,424 external-priority patent/US5472682A/en
Application filed by Nycomed Imaging As filed Critical Nycomed Imaging As
Publication of NO964451D0 publication Critical patent/NO964451D0/no
Publication of NO964451L publication Critical patent/NO964451L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0461—Dispersions, colloids, emulsions or suspensions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/04—X-ray contrast preparations
    • A61K49/0433—X-ray contrast preparations containing an organic halogenated X-ray contrast-enhancing agent
    • A61K49/0447—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound
    • A61K49/0495—Physical forms of mixtures of two different X-ray contrast-enhancing agents, containing at least one X-ray contrast-enhancing agent which is a halogenated organic compound intended for oral administration
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82Y—SPECIFIC USES OR APPLICATIONS OF NANOSTRUCTURES; MEASUREMENT OR ANALYSIS OF NANOSTRUCTURES; MANUFACTURE OR TREATMENT OF NANOSTRUCTURES
    • B82Y5/00—Nanobiotechnology or nanomedicine, e.g. protein engineering or drug delivery

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Nanotechnology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Medical Informatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dispersion Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
NO964451A 1994-04-21 1996-10-18 Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer NO964451L (no)

Applications Claiming Priority (8)

Application Number Priority Date Filing Date Title
US08/230,580 US5476646A (en) 1992-05-01 1994-04-21 X-ray contrast compositions containing iodophenoxyalkanes and pharmaceutically acceptable clays
US08/236,287 US5424056A (en) 1993-03-01 1994-04-29 X-ray contrast compositions containing iodoaniline derivatives and pharmaceutically acceptable clays
US08/237,502 US5492687A (en) 1993-03-11 1994-05-03 Compositions of iodophenoxy alkylene ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/239,090 US5484585A (en) 1993-03-11 1994-05-05 Compositions of iodobenzoic acid derivatives and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/247,424 US5360604A (en) 1994-04-14 1994-05-23 X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays
US08/247,438 US5531979A (en) 1993-02-02 1994-05-23 Compositions of iodophenoxy alkanes and iodophenyl ethers and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
US08/249,424 US5472682A (en) 1993-03-31 1994-05-26 Compositions of iodophenyl esters and iodophenyl sulfonates and pharmaceutically acceptable clays for visualization of the gastrointestinal tract
PCT/GB1995/000566 WO1995028969A1 (fr) 1994-04-21 1995-03-16 Compositions de contraste radiologique contenant des argiles acceptables sur le plan pharmacologique

Publications (2)

Publication Number Publication Date
NO964451D0 NO964451D0 (no) 1996-10-18
NO964451L true NO964451L (no) 1996-12-18

Family

ID=27569393

Family Applications (1)

Application Number Title Priority Date Filing Date
NO964451A NO964451L (no) 1994-04-21 1996-10-18 Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer

Country Status (9)

Country Link
EP (1) EP0756497A1 (fr)
JP (1) JPH09512029A (fr)
CN (1) CN1147206A (fr)
AU (1) AU1897795A (fr)
CA (1) CA2187019A1 (fr)
FI (1) FI964212A0 (fr)
HU (1) HUT76304A (fr)
NO (1) NO964451L (fr)
WO (1) WO1995028969A1 (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5466440A (en) * 1994-12-30 1995-11-14 Eastman Kodak Company Formulations of oral gastrointestinal diagnostic X-ray contrast agents in combination with pharmaceutically acceptable clays
JP4670229B2 (ja) * 2003-06-10 2011-04-13 味の素株式会社 Ｃｔコロノグラフィにおける消化管造影用組成物
AP2006003700A0 (en) 2004-02-13 2006-08-31 Warner Lambert Co Androgen receptor modulators
CA2563291A1 (fr) 2004-04-13 2005-10-27 Warner-Lambert Company Llc Derives de 4-cyanophenoxy-alkylcarboxyle comme modulateurs androgenes
WO2005102990A1 (fr) 2004-04-22 2005-11-03 Warner-Lambert Company Llc Modulateurs des androgenes
BRPI0513020A (pt) 2004-07-08 2008-04-22 Warner Lambert Co moduladores de andrÈgenio, seus usos, composição farmacêutica, formulação farmacêutica tópica e artigo de fabricação
CN1330380C (zh) * 2005-03-18 2007-08-08 山东师范大学 一种x－射线造影剂组合物
TW200724139A (en) 2005-05-05 2007-07-01 Warner Lambert Co Androgen modulators
WO2014145509A1 (fr) 2013-03-15 2014-09-18 The Regents Of The University Of California Matière de contraste de tomographie assistée par ordinateur (ct) entérique basée sur atomes de z moins élevé
WO2015024025A1 (fr) 2013-08-16 2015-02-19 The Regents Of The University Of California Produit de contraste à base de silicium pour administration par voie entérale pour examen par scanner
CN106075476B (zh) * 2016-07-30 2019-05-31 温州市人民医院 一种造影剂

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB767788A (en) * 1953-12-28 1957-02-06 Schering Corp Polyiodinated phenyl fatty acid compounds and process for their manufacture
CH338274A (fr) * 1954-01-08 1959-05-15 Schering Corp Utilisation comme agents radio-opaques de phénoxy-acides gras polyiodés
CA985626A (en) * 1970-03-10 1976-03-16 E.R. Squibb And Sons Coating composition for moist surface
CA2094893A1 (fr) * 1992-05-01 1993-11-02 Carl R. Illig Agents de contraste contenant des substances filmogenes pour la radiographie
US5260049A (en) * 1992-05-01 1993-11-09 Sterling Winthrop Inc. X-ray contrast compositions comprising alkoxyphenols
NZ250063A (en) * 1992-12-14 1996-03-26 Eastman Kodak Co Iodinated aromatic acid ester derivatives; x-ray contrast compositions
US5322679A (en) * 1992-12-16 1994-06-21 Sterling Winthrop Inc. Iodinated aroyloxy esters
US5316755A (en) * 1993-02-02 1994-05-31 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers for visualization of the gastrointestinal tract
US5326553A (en) * 1993-02-02 1994-07-05 Sterling Winthrop Inc. Compositions of iodophenoxy alkanes and iodophenyl ethers in film-forming materials for visualization of the gastrointestinal tract
US5334370A (en) * 1993-02-04 1994-08-02 Sterling Winthrop Inc. Compositions of alkylbenzenes in film-forming materials for visualization of the gastrointestinal tract
US5308607A (en) * 1993-02-04 1994-05-03 Sterling Winthrop Inc. Compositions of alkylbenzenes for visualization of the gastrointestinal tract using X-ray contrast
US5310537A (en) * 1993-03-01 1994-05-10 Sterling Winthrop Inc. Compositions of iodoaniline derivatives for visualization of the gastrointestinal tract
US5310538A (en) * 1993-03-11 1994-05-10 Sterling Winthrop Inc. Compositions of iodophenoxy alkylene ethers in film-forming materials for visualization of the gastrointestinal tract
US5344638A (en) * 1993-03-11 1994-09-06 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives for visualization of the gastrointestinal tract
US5312616A (en) * 1993-03-11 1994-05-17 Sterling Winthrop Inc. Compositions of iodobenzoic acid derivatives in film-forming materials for visualization of the gastrointestinal tract
US5318769A (en) * 1993-03-31 1994-06-07 Sterling Winthrop Inc. Compositions of iodophenyl esters for X-ray visualization of the gastrointestinal tract
US5336484A (en) * 1993-03-31 1994-08-09 Sterling Winthrop Inc. Compositions of iodophenyl esters and iodophenyl sulfonates in film-forming materials for visualization of the gastronintestinal tract
US5360604A (en) * 1994-04-14 1994-11-01 Sterling Winthrop Inc. X-ray contrast compositions containing an organic crystalline X-ray contrast agent in combination with pharmaceutically acceptable clays

Also Published As

Publication number Publication date
NO964451D0 (no) 1996-10-18
EP0756497A1 (fr) 1997-02-05
WO1995028969A1 (fr) 1995-11-02
AU1897795A (en) 1995-11-16
HUT76304A (en) 1997-07-28
MX9604899A (es) 1998-03-31
FI964212A (fi) 1996-10-18
JPH09512029A (ja) 1997-12-02
FI964212A0 (fi) 1996-10-18
CN1147206A (zh) 1997-04-09
HU9602908D0 (en) 1996-12-30
CA2187019A1 (fr) 1995-11-02

Similar Documents

Publication Publication Date Title
EE04578B1 (et) Farmatseutiline kompositsioon N-piperidino-3-pürasoolkarboksamiidi derivaadi, tema soolade ja nendesolvaatide suu kaudu manustamiseks
AU8296987A (en) Pharmaceutical composition comprising fluticasone propionate
NO964451L (no) Röntgenkontrastblandinger inneholdende farmasöytisk akseptable leirer
NO973459L (no) Vismut-forbindelser
ATE308328T1 (de) Pharmazeutische zusammensetzung enthaltend clindamycin und clotrimazol, zur behandlung vaginaler infektionen
NO163435C (no) Pasientstol for roentgenundersoekelser.
GB9524934D0 (en) Treatment and diagnosis of infections due to helicobacter pylori
EE9900450A (et) Tetrahüdropüridoühendid, neid sisaldav ravim ja nende kasutamine
DE59007439D1 (de) Zahnärztliche Röntgendiagnostikeinrichtung.
MX9302501A (es) Composiciones radiograficas de contraste, y metodos para su uso en la visualizacion del conducto intestinal
ATE74605T1 (de) Tetracyclische chinazolinderivate, herstellung und verwendung.
NO963540L (no) Röntgenkontrastblandinger som inneholder cellulosederivater
ES2024695B3 (es) Proceso y dispositivo para la esterilizacion de los conductos de nebulizacion y/o alimentacion de aire de los instrumentos medicos, en especial instrumentos de cirujia dental.
ES2039211T3 (es) Nuevos n-glicosilamidoderivados, procedimientos para su obtencion y su empleo como medicamentos.
NO954695D0 (no) Jod-borforbindelser egnet som röntgenkontrastmidler, og farmasöytiske forbindelser derav
AU8144894A (en) Biphenyl iodinated derivatives and their diagnostic use
DE69916356D1 (de) Schwenkbarer Patiententisch, insbesondere für Röntgenuntersuchungen
IT1276651B1 (it) Apparecchiatura radiografica per diagnosi odontoiatriche
IT1270088B (it) Derivati aromatici iodurati e loro impiego diagnostico
FI892577A (fi) Vattenhaltig framkallarkomposition foer med loesningsmedel framkallbara fotoresistbelaeggningar.
ES2179029T3 (es) Derivados de 14,15-alfa-metileno-equilenina, proceso para su preparacion y medicamentos que contienen los mismos.
IT212607Z2 (it) Motorcaravan sanitario di emergenza per diagnostica clinica, radiologia e di laboratorio, e terapia medica
ES2112765A1 (es) Procedimiento para la obtencion de formulaciones de constraste radiologico, para exploraciones gastrointestinales de uso extemporaneo y directo.
SE9503375D0 (sv) Mobilt patientbord för röntgen-, MR- eller liknande undersökningar
MX9710126A (es) Compuestos sustituidos con sulfonamida, procedimiento para su preparacion, su empleo como medicamento o agente de diagnostico, asi como preparados farmaceuticos que los contienen.